Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12208093
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)
granted -
CN 119365549
Fluorescent probe targeting CA-IX
granted -
WO 2025018295
BACTÉRIOPHAGE MODIFIÉ
granted -
CN 119343336
1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents
granted -
US 12202797
Method for producing pyrrole compound
granted -
US 12201617
HDAC6 inhibitors for treatment of metabolic disease and HFpEF
granted -
US 12201591
Sustained release compositions of endoxifen
granted -
US 12202902
FLT3-specific chimeric antigen receptors and methods using same
granted -
US 12201673
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 12201699
Compositions and methods for promoting homology directed repair
granted -
US 12201598
Immunoregulatory microparticles for modulating inflammatory arthritides
granted -
US 12202895
LILRB4 antibodies and uses thereof
granted -
US 12201700
Micro- and nano-device for cartilage injury detection and treatment
granted -
US 12201719
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
granted -
US 12203143
Methods and kits to identify Klebsiella strains
granted -
US 12201604
Treatment of circadian rhythm disorders
granted -
US 12202883
Anti-VEGF protein compositions and methods for producing the same
granted -
US 12202832
Heterocyclic compounds having a calcium-sensing receptor antagonistic activity
granted -
US 12201639
Aqueous oral pharmaceutical suspension compositions
granted -
US 12201601
Treatment for obesity
granted -
US 12201655
Antimicrobial therapy
granted -
US 12201593
Oral pharmaceutical formulations of bitter compounds for asthma
granted -
US 12203098
Cells having solid tumor targeting backbone and use thereof
granted -
US 12202901
Cannabinoid receptor type 1 (CB1) antibodies, encoding nucleic acid molecules thereof and methods of use thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.